Microglia calcium signals drive fine process retraction and promote susceptibility to status epilepticus. // Cell Calcium. – URL: https://www.sciencedirect.com/science/article/pii/S0143416026000916?dgcid=rss_sd_all
Microglia calcium signals drive fine process retraction and promote susceptibility to status epilepticus. Cell Calcium. https://www.sciencedirect.com/science/article/pii/S0143416026000916?dgcid=rss_sd_all
“Microglia calcium signals drive fine process retraction and promote susceptibility to status epilepticus.” Cell Calcium.
@article{article39956,
title = {Microglia calcium signals drive fine process retraction and promote susceptibility to status epilepticus},
journal = {Cell Calcium},
url = {https://www.sciencedirect.com/science/article/pii/S0143416026000916?dgcid=rss_sd_all}
}
Gene Therapy, Published online: 13 November 2026; doi:10.1038/s41434-026-00658-6 Clinical landscape of gene therapy for rare diseases: a registry-based analysis of clinical trials and FDA-approved products
Human Genome Variation, Published online: 12 November 2026; doi:10.1038/s41439-026-00361-3 Arthrogryposis involves multiple joint contractures present at birth, affecting both upper and lower extremities. This study investigates the...
Gene Therapy, Published online: 10 November 2026; doi:10.1038/s41434-026-00657-7 Perspectives on cell and gene therapy: insights from the 5th China Annual Congress on CGT
Gene Therapy, Published online: 04 November 2026; doi:10.1038/s41434-026-00649-7 High-resolution separation and quantification of dual-AAV drug products by density gradient equilibrium analytical ultracentrifugation
Gene Therapy, Published online: 03 November 2026; doi:10.1038/s41434-026-00656-8 Genotoxic safety and long-term engraftment dynamics of efficient translational CRISPR/Cas9 therapeutics for β-haemoglobinopathies from bench to clinical trials